Development of high-content imaging assays for lethal viral pathogens

Journal of Biomolecular Screening

Volumn 15, Issue 7, 2010, Pages 755-765

  Panchal, Rekha G ^a   Kota, Krishna P ^b   Spurgers, Kevin B ^a   Ruthel, Gordon ^a   Tran, Julie P ^a   Boltz, Robert C ^b   Bavari, Sina ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b PERKINELMER INC   (United States)

Author keywords

Ebola; filoviruses; high content; imaging; Marburg

Indexed keywords

ARTICLE; CELL COUNT; CELL HETEROGENEITY; CELLULAR DISTRIBUTION; DRUG SCREENING; EBOLA VIRUS; FILOVIRUS INFECTION; FLUORESCENCE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MARBURG VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; WHOLE CELL;

ANIMALS; ANTIVIRAL AGENTS; AUTOMATION; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; GREEN FLUORESCENT PROTEINS; HEMORRHAGIC FEVER, EBOLA; HIGH-THROUGHPUT SCREENING ASSAYS; IMAGING, THREE-DIMENSIONAL; MARBURG VIRUS DISEASE; MARBURGVIRUS; VERO CELLS; VIRUS REPLICATION;

MARBURGVIRUS; RNA VIRUSES;

EID: 77956016060     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057110374357     Document Type: Article

References (24)

1. Brown DW: Threat to humans from virus infections of non-human primates. Rev Med Virol 1997 ; 7: 239-246.
2. Feldmann H., Kiley MP: Classification, structure, and replication of filoviruses. Curr Top Microbiol Immunol 1999 ; 235: 1-21.
3. Jaax N., Jahrling P., Geisbert T., Geisbert J., Steele K., McKee K.,, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 ; 346: 1669-1671.
4. Johnson E., Jaax N., White J., Jahrling P.: Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995 ; 76: 227-236.
5. Moe JB, Lambert RD, Lupton HW: Plaque assay for Ebola virus. J Clin Microbiol 1981 ; 13: 791-793.
6. Drosten C., Gottig S., Schilling S., Asper M., Panning M., Schmitz H.,, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002 ; 40: 2323-2330.
7. Murakami Y., Noguchi K., Yamagoe S., Suzuki T., Wakita T., Fukazawa H.: Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR. Antiviral Res 2009 ; 83: 112-117.
8. Naze F., Le Roux K., Schuffenecker I., Zeller H., Staikowsky F., Grivard P.,, et al. Simultaneous detection and quantitation of Chikungunya, dengue and West Nile viruses by multiplex RT-PCR assays and dengue virus typing using high resolution melting. J Virol Methods 2009 ; 162: 1-7.
9. Towner JS, Sealy TK, Ksiazek TG, Nichol ST: High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis 2007 ; 196 (suppl 2). S205 - S212.
10. Bavari S., Bosio CM, Wiegand E., Ruthel G., Will AB, Geisbert TW,, et al. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 2002 ; 195: 593-602.
11. Panchal RG, Ruthel G., Kenny TA, Kallstrom GH, Lane D., Badie SS,, et al. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci U S A 2003 ; 100: 15936-15941.
12. Kallstrom G., Warfield KL, Swenson DL, Mort S., Panchal RG, Ruthel G.,, et al. Analysis of Ebola virus and VLP release using an immunocapture assay. J Virol Methods 2005 ; 127: 1-9.
13. Sanchez A.: Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis 2007 ; 196 (suppl 2). S251 - S258.
14. Wool-Lewis RJ, Bates P.: Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 1998 ; 72: 3155-3160.
15. Noda T., Sagara H., Suzuki E., Takada A., Kida H., Kawaoka Y.,, et al. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol 2002 ; 76: 4855-4865.
16. Carpenter AE: Image-based chemical screening. Nat Chem Biol 2007 ; 3: 461-465.
17. Towner JS, Paragas J., Dover JE, Gupta M., Goldsmith CS, Huggins JW,, et al. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 2005 ; 332: 20-27.
18. Warfield KL, Posten NA, Swenson DL, Olinger GG, Esposito D., Gillette WK,, et al. Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents. J Infect Dis 2007 ; 196 (suppl 2). S421 - S429.
19. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4: 67-73.
20. Inglese J., Johnson RL, Simeonov A., Xia M., Zheng W., Austin CP,, et al. High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 2007 ; 3: 466-479.
21. Turk D., Hall MD, Chu BF, Ludwig JA, Fales HM, Gottesman MM,, et al. Identification of compounds selectively killing multidrug-resistant cancer cells. Cancer Res 2009 ; 69: 8293-8301.
22. Berkson RG, Hollick JJ, Westwood NJ, Woods JA, Lane DP, Lain S.: Pilot screening programme for small molecule activators of p53. Int J Cancer 2005 ; 115: 701-710.
23. Stockwin LH, Yu SX, Stotler H., Hollingshead MG, Newton DL: ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC. BMC Cancer 2009 ; 9: 63.
24. Aman MJ, Kinch MS, Warfield K., Warren T., Yunus A., Enterlein S.,, et al. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Res 2009 ; 83: 245-251.